NGS-Based RNA Sequencing Market: Size, Share, Trends and Forecast to 2033

May 19, 2026

” NGS-Based RNA-Sequencing Market Summary:

According to the latest report published by Data Bridge Market Research, the NGS-Based RNA-Sequencing Market

CAGR Value

Global NGS-based RNA-sequencing market size was valued at USD 4.21 billion in 2024 and is projected to reach USD 17.96 billion by 2032, with a CAGR of 19.90% during the forecast period of 2025 to 2032.

This world-wide NGS-Based RNA-Sequencing Market report is generated by a team of multilingual researchers who are skilled at different languages and hence perform market research internationally. With this report, businesses can get clear idea about how the market is going to perform in the forecast years with understandable details about market definition, classifications, applications, and engagements. A genius team along with project managers serve the clients on every strategic aspect including product development, key areas of development, application modelling, use of technologies, the acquisition strategies, exploring niche growth opportunities and new markets.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-market

NGS-Based RNA-Sequencing Market Segmentation and Market Companies

Segments

By Product Type: The NGS-based RNA-sequencing market can be segmented by product type into sample preparation, sequencing, data analysis, and storage. The sample preparation segment includes library preparation kits, RNA purification kits, and other related products. The sequencing segment comprises platforms such as Illumina sequencing, Ion Torrent sequencing, and other sequencing technologies. Data analysis tools and software are crucial for interpreting the sequencing data, while storage solutions are necessary to manage the vast amount of data generated.
By Application: In terms of applications, the market can be segmented into transcriptome profiling, differential gene expression analysis, RNA editing, small RNA sequencing, and others. Transcriptome profiling is the most common application of NGS-based RNA-sequencing, helping researchers understand the complete set of RNA transcripts in a cell or tissue. Differential gene expression analysis is essential for comparing gene expression levels between different conditions, such as healthy vs. diseased tissue. RNA editing and small RNA sequencing are specialized applications that focus on specific aspects of RNA biology.
By End-User: The end-user segmentation of the market includes academic research institutes, pharmaceutical & biotechnology companies, contract research organizations (CROs), and others. Academic research institutes are significant users of NGS-based RNA-sequencing for basic research and molecular biology studies. Pharmaceutical and biotechnology companies utilize RNA-sequencing for drug discovery, biomarker identification, and precision medicine applications. CROs provide sequencing services to researchers who may not have in-house capabilities or expertise.

Market Players

Illumina, Inc.
Thermo Fisher Scientific Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
GENEWIZ
Zymo Research
QIAGEN
Eurofins Scientific
BGI Group
Macrogen, Inc.

The global NGS-based RNA-sequencing market is characterized by intense competition and rapid technological advancements. Key players such as Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies dominate the market with their innovative product offerings and strong distribution networks. Other notable market players like Pacific Biosciences, PerkinElmer, and GENEWIZ also play a significant role in driving market growth through product development and strategic partnerships. The market is expected to witness further consolidation as companies focus on expanding their product portfolios and enhancing their market presence.

The NGS-based RNA-sequencing market is poised for substantial growth due to the increasing demand for advanced genomics technologies in research and clinical applications. One emerging trend in the market is the rising adoption of single-cell RNA-sequencing (scRNA-seq) techniques, enabling researchers to analyze gene expression at the individual cell level. This technique provides valuable insights into cellular heterogeneity, developmental processes, and disease mechanisms, driving its widespread use in fields such as oncology, immunology, and stem cell research.

Moreover, the market is witnessing a shift towards integrated sequencing solutions that offer end-to-end workflows, from sample preparation to data analysis. Companies are investing in developing automated and user-friendly platforms that streamline the sequencing process, reduce turnaround times, and improve data accuracy. These integrated solutions appeal to a broader user base, including researchers with varying levels of expertise in genomics, thereby driving market growth.

Another significant market driver is the expanding application of NGS-based RNA-sequencing in personalized medicine and clinical diagnostics. The technology allows for precise profiling of gene expression patterns, identification of disease biomarkers, and monitoring of treatment responses, facilitating the development of targeted therapies and personalized treatment strategies. As the healthcare industry increasingly adopts genomic technologies for patient care, the demand for NGS-based RNA-sequencing in clinical settings is expected to surge.

Furthermore, collaborations and partnerships among market players are shaping the competitive landscape of the NGS-based RNA-sequencing market. Companies are entering into strategic alliances to leverage complementary strengths, access new markets, and accelerate product development. Collaborations between sequencing technology providers, bioinformatics companies, and research institutions are driving innovation in data analysis tools, cloud-based solutions, and artificial intelligence applications, enhancing the overall efficiency and value of RNA-sequencing workflows.

In terms of market dynamics, regulatory considerations and data privacy concerns are key challenges facing market players in the NGS-based RNA-sequencing industry. As the use of genomic data expands, regulatory bodies are implementing stringent guidelines to ensure data security, patient confidentiality, and ethical handling of genetic information. Companies investing in compliance measures and data protection strategies will be better positioned to navigate the evolving regulatory landscape and maintain consumer trust in genomic technologies.

Overall, the global NGS-based RNA-sequencing market is poised for continued growth driven by technological advancements, expanding applications in research and healthcare, and strategic collaborations among industry players. As the market matures, companies that innovate, differentiate their product offerings, and address regulatory challenges will be well-positioned to capitalize on the evolving opportunities in this dynamic market landscape.The global NGS-based RNA-sequencing market is experiencing significant growth propelled by various factors. One key driver is the continual innovation and advancement in sequencing technologies, enabling researchers to delve deeper into the complexities of RNA biology. The advent of single-cell RNA sequencing (scRNA-seq) has revolutionized the field by allowing the examination of gene expression at the individual cell level, providing insights into cellular heterogeneity and disease mechanisms. This technique has found applications in diverse fields such as oncology, immunology, and developmental biology, driving its increasing adoption and contributing to market expansion.

Moreover, the market is witnessing a shift towards integrated sequencing solutions that streamline the entire workflow from sample preparation to data analysis. This integrated approach not only enhances efficiency but also caters to a wider user base by providing user-friendly platforms that reduce turnaround times and improve data accuracy. The demand for such integrated solutions is expected to rise as researchers, including those with varying levels of genomics expertise, seek streamlined processes and reliable results, thus boosting market growth.

An emerging trend in the market is the burgeoning application of NGS-based RNA-sequencing in personalized medicine and clinical diagnostics. The technology's ability to profile gene expression, identify disease biomarkers, and monitor treatment responses is crucial for developing targeted therapies and personalized treatment strategies. As the healthcare sector increasingly embraces genomic technologies for patient care, the demand for NGS-based RNA-sequencing in clinical settings is anticipated to surge, presenting lucrative opportunities for market players.

Collaborations and partnerships among industry players are also shaping the competitive landscape of the market. Strategic alliances allow companies to leverage each other's strengths, access new markets, and expedite product development, fostering innovation in data analysis tools, cloud-based solutions, and artificial intelligence applications. These collaborations enhance the overall efficiency of RNA-sequencing workflows, driving market growth and differentiation among competitors.

However, market players face regulatory challenges and data privacy concerns as genomic data usage expands. Compliance with stringent regulations regarding data security, patient confidentiality, and ethical handling of genetic information is crucial to maintain consumer trust and navigate the evolving regulatory landscape. Companies investing in robust compliance measures and data protection strategies will be better equipped to address these challenges, thereby sustaining their market presence and credibility in the dynamic NGS-based RNA-sequencing market.

In conclusion, the global NGS-based RNA-sequencing market is poised for sustained growth driven by technological advancements, expanding applications in research and healthcare, and strategic collaborations among industry players. Companies that focus on innovation, develop differentiated products, and address regulatory hurdles will be well-positioned to capitalize on the evolving opportunities within this dynamic market environment.

Learn about the company’s position within the industry https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-market/companies

Frequently Asked Questions About This Report

Is the NGS-Based RNA-Sequencing Market currently in the growth or maturity stage? How is Social Responsibility impacting the NGS-Based RNA-Sequencing Market share? How will Quantum Computing disrupt the NGS-Based RNA-Sequencing Market by 2033? How does the Premiumization trend affect NGS-Based RNA-Sequencing Market consumer choices? How does the NGS-Based RNA-Sequencing Market in Europe address data privacy concerns? What are the bottlenecks in the NGS-Based RNA-Sequencing Market supply chain? What is the lifetime value (LTV) of a NGS-Based RNA-Sequencing Market customer? What is the estimated market valuation for NGS-Based RNA-Sequencing Market in 2026? How much will the NGS-Based RNA-Sequencing Market valuation grow if AI adoption doubles? What is the PESTLE analysis for the global NGS-Based RNA-Sequencing Market industry? What is the expected exit strategy for NGS-Based RNA-Sequencing Market start-ups? What is the margin structure across the NGS-Based RNA-Sequencing Market value chain? What is the valuation of NGS-Based RNA-Sequencing Market in the Renewable Energy market?

Browse More Reports:

Southeast Asia Aesthetic Services Market Global Cell Therapy Market Global Electronic Specialty Gas Market Global Minimally Invasive Surgery Market Global Digital Twin Market Global Isocyanate Market Global Used Cooking Oil Market Global Hair Loss Treatment Products Market Global Vegan Dog Food Market Global Agricultural Biotechnology Market Global Epigenetics Diagnostic Market Global Mobility as A Service Market Global Nurse Call System Market Global Pine Nuts Market Global Revenue Cycle Management (RCM) Market

Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 980 Email:– [email protected]”